newsfilter.io

Jay Rughani

Showing 1–3 of 3 transcripts.

  1. a16z25 min

    Mastering Your Data with Sajith Wickramasekara

    Sajith Wickramasekara, Jorge Conde, Jay Rughani

    Founded in 2012 by a software engineer before CRISPR's mainstream adoption, Benchling has scaled into a platform serving over 200,000 scientists across 32 countries with $200 million in annualized revenue. The company evolved from a productivity tool into an essential data infrastructure provider, addressing the critical lack of structured data required to unlock AI's potential for accelerating drug discovery and manufacturing. Future strategies focus on unifying this aggregated data into a cohesive ecosystem to optimize therapeutic development from molecule design through clinical approval.

  2. a16z27 min

    The Future of Health Insurance in a Work Remote World

    Chris Ellis, Adam Stevenson, Julie Yoo, Jay Rughani

    Thatch is deploying fintech solutions to operationalize Individual Coverage Health Reimbursement Arrangements, shifting employer-sponsored healthcare from a static, tied model to a portable system that mirrors the 401(k) evolution. By enabling tax-free funding for workers to purchase individual plans, the platform addresses labor market friction where fear of coverage loss inhibits mobility while driving triple-digit carrier growth as traditional sectors stagnate. Early adoption data shows 40% of users growing monthly balances, signaling a trajectory toward a competitive market where free funds can be reallocated to preventative care and niche insurance providers.

  3. a16z39 min

    Two-Sided Networks in Healthcare - a Founder's Playbook

    Vineeta Agarwala, Jay Rughani, Vinita, Arif Nthu, Andrew Adams, Iman Abouzeid, Thomas Closel, Doug Hirsch

    This event explores the architecture of two-sided healthcare networks that connect the "five P's" of the industry to bridge fragmented data silos and create self-reinforcing value loops. Founders and investors detail specific go-to-market strategies, such as prioritizing demand or supply first, while emphasizing the critical need for early trust-building and the rejection of vanity metrics in favor of qualitative product validation. The discussion further outlines frameworks for scaling to a second side, maintaining network neutrality to prevent disintermediation, and evaluating defensibility against direct transactions as healthcare data infrastructure expands.